Literature DB >> 7835233

Inhibition of p-nitrophenol hydroxylase in rat liver microsomes by small aromatic and heterocyclic molecules.

M B Hargreaves1, B C Jones, D A Smith, A Gescher.   

Abstract

The cytochrome P450 isoenzyme P4502E1 is constitutively expressed in human liver and catalyzes the oxidation of many known or suspected carcinogens of low molecular weight. In this structure-metabolism study, the role that heteroatoms in heterocyclic compounds play in determining their affinity for P4502E1 was investigated. The ability of 16 six-membered and 10 five-membered compounds to inhibit the hydroxylation of p-nitrophenol, which is specifically catalyzed by P4502E1, was studied in suspensions of microsomes from rat livers in which P4502E1 had been induced by inclusion of acetone in the drinking water. Apparent Ki values were extrapolated from kinetic models of Dixon or Cornish-Bowden plots for enzyme inhibition. Enzyme inhibition was generally of the non-or uncompetitive type. Pyridine was the most potent and benzene one of the least potent inhibitors, with Ki values of 0.4 microM and 8,400 microM, respectively. Pyridazine was less inhibitory than 1,3,5-triazine, which inhibited P4502E1 to a lesser degree than pyrazine and pyrimidine. Among the unsubstituted unsaturated five-membered ring molecules, pyrrole was a better inhibitor than furan or thiophene. 4-Methylimidazole was a much stronger inhibitor than imidazole or 1-and 2-methylimidazole. The ability of compounds to inhibit P4502E1 seems to depend in the main on the presence of a nitrogen atom in the molecule and on the ability of the nitrogen lone pair of electrons to ligand to the heme.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835233

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).

Authors:  X Wen; J S Wang; K T Kivistö; P J Neuvonen; J T Backman
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

2.  CYP2E1 metabolism of styrene involves allostery.

Authors:  Jessica H Hartman; Gunnar Boysen; Grover P Miller
Journal:  Drug Metab Dispos       Date:  2012-07-17       Impact factor: 3.922

3.  Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates.

Authors:  Jessica H Hartman; H Cass Martin; Andres A Caro; Amy R Pearce; Grover P Miller
Journal:  Toxicology       Date:  2015-10-14       Impact factor: 4.221

4.  Sex steroid hormones regulate constitutive expression of Cyp2e1 in female mouse liver.

Authors:  Maria Konstandi; Jie Cheng; Frank J Gonzalez
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-02       Impact factor: 4.310

5.  Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations.

Authors:  Joseph W Levy; Jessica H Hartman; Martin D Perry; Grover P Miller
Journal:  J Mol Graph Model       Date:  2014-12-06       Impact factor: 2.518

6.  Cooperative effects for CYP2E1 differ between styrene and its metabolites.

Authors:  Jessica H Hartman; Gunnar Boysen; Grover P Miller
Journal:  Xenobiotica       Date:  2013-01-18       Impact factor: 1.908

7.  Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures.

Authors:  Jessica H Hartman; Lynda G Letzig; Dean W Roberts; Laura P James; E Kim Fifer; Grover P Miller
Journal:  Biochem Pharmacol       Date:  2015-07-28       Impact factor: 5.858

8.  CYP2E1 substrate inhibition. Mechanistic interpretation through an effector site for monocyclic compounds.

Authors:  Samuel L Collom; Ryan M Laddusaw; Amber M Burch; Petr Kuzmic; Martin D Perry; Grover P Miller
Journal:  J Biol Chem       Date:  2007-12-04       Impact factor: 5.157

9.  Fast Extraction and Detection of 4-Methylimidazole in Soy Sauce Using Magnetic Molecularly Imprinted Polymer by HPLC.

Authors:  Zufei Feng; Yan Lu; Yingjuan Zhao; Helin Ye
Journal:  Molecules       Date:  2017-11-02       Impact factor: 4.411

10.  Food Safety and Nutraceutical Potential of Caramel Colour Class IV Using In Vivo and In Vitro Assays.

Authors:  Marcos Mateo-Fernández; Pilar Alves-Martínez; Mercedes Del Río-Celestino; Rafael Font; Tania Merinas-Amo; Ángeles Alonso-Moraga
Journal:  Foods       Date:  2019-09-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.